Continuous Versus Bolus Administration of Norepinephrine to Treat Hypotension During Anesthetic Induction

Last updated: November 13, 2024
Sponsor: Kristen Thomsen
Overall Status: Completed

Phase

N/A

Condition

Vascular Diseases

Circulation Disorders

Dizzy/fainting Spells

Treatment

Continuous norepinephrine administration

Clinical Study ID

NCT05940649
2023-100999-BO-ff
  • Ages > 45
  • All Genders

Study Summary

Intraoperative hypotension is common in patients having non-cardiac surgery with general anesthesia and is associated with organ injury and death. The timely treatment of intraoperative hypotension is thus important to avoid postoperative complications. About one third of intraoperative hypotension occurs during anesthetic induction - i.e., between the start of anesthetic induction and surgical incision. Hypotension during anesthetic induction is associated with postoperative acute kidney injury.

Unmodifiable risk factors for hypotension during anesthetic induction include age, male sex, and a high American Society of Anesthesiologists physical status class. However, hypotension during anesthetic induction is mainly driven by modifiable factors - specifically, anesthetic drugs that cause vasodilation.

In most German hospitals, norepinephrine is the first-line vasopressor to treat hypotension during anesthetic induction. Norepinephrine is usually given as repeated manual boluses of 5, 10, or 20 μg. The continuous administration of norepinephrine via a perfusion pump is usually started only later. It remains unknown whether giving norepinephrine continuously - compared to giving it as repeated manual boluses - reduces hypotension during anesthetic induction.

We thus propose to investigate whether giving norepinephrine continuously - compared to giving it as repeated manual boluses - reduces hypotension during anesthetic induction in non-cardiac surgery patients.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • non-cardiac surgery

  • >45 years of age

  • American Society of Anesthesiologists physical status classification II, III, andIV.

Exclusion

Exclusion Criteria:

  • Planned intraarterial blood pressure monitoring during anesthetic induction with anarterial catheter

  • Emergency surgery

  • Transplant surgery

  • History of organ transplant

  • Pregnancy

  • Heart rhythms other than sinus rhythm

  • Impossible Finger-cuff blood pressure monitoring

  • Rapid sequence induction

Study Design

Total Participants: 262
Treatment Group(s): 1
Primary Treatment: Continuous norepinephrine administration
Phase:
Study Start date:
July 03, 2023
Estimated Completion Date:
July 01, 2024

Connect with a study center

  • University Medical Center Hamburg-Eppendorf

    Hamburg, 20251
    Germany

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.